510(k) K181492

Device
Elecsys CA 15-3 II
Applicant
Roche Diagnostics
510(k) number
K181492
Product code
MOI  
Decision
Substantially Equivalent (SESE)
Decision date
2018-06-22
Date received
2018-06-06
Regulation
866.6010
Classification name
System, Test, Immunological, Antigen, Tumor
Medical specialty
Immunology
Review panel
Immunology
Device class
2
Clearance type
Traditional
Statement or summary
Summary
Third party reviewed
No

Applicant Contact#

Contact
Adennis Cora
Address
9115 Hague Rd. P.O. Box 50416 Indianapolis IN US 46250 46250

FDA Registration Numbers#

Source Documents#

510(k) summary PDF

Other 510(k) Records For Product Code MOI  #

510(k), Device, Applicant table
510(k)DeviceApplicantDecision date
K240403Access BR MonitorBeckman Coulter, Inc.2024-05-09
K233946IMMULITE® 2000 BR-MASiemens Healthcare Diagnostics Products, Ltd.2024-03-13
K192524Lumipulse G CA15-3Fujirebio Diagnostics,Inc.2020-09-04
K193489ADVIA Centaur BRSiemens Healthcare Diagnostics, Inc.2020-02-13
K192777ADVIA Centaur CA 15-3 assaySiemens Healthcare Diagnostics, Inc.2019-11-22
K171605Elecsys CA 15-3 IIRoche Diagnostics2018-02-20
K100344DIMENSION VISTA LOCI CA 15-3 FLEX REAGENT CARTRIDGE, DIMENSION VISTA LOCI 7 CALIBRATOR, MODELS: K6456 AND KC605Siemens Healthcare Diagnostics2011-04-18
K072612ACCESS IMMUNOASSAY SYSTEMS BR MONITOR, AND CALIBRATORS, MODEL(S) 387620,AND 387647Beckman Coulter, Inc.2007-10-26
K042732ARCHITECT CA 15-3 ASSAYFujirebio Diagnostics,Inc.2004-12-22
K033036BR MONITOR AND BR MONITOR CALIBRATORS ON THE ACCESS IMMUNOASSAY SYSTEMS, MODEL 387620, 387647Beckman Coulter, Inc.2004-02-03
K022178CA 15-3 ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEMBayer Diagnostics Corp.2002-11-12
K013984IMMULITE BR-MA, MODEL #LKBR; IMMULITE 2000 BR-MA, MODEL #L2KBRDiagnostic Products Corp.2002-03-28
K012357CA 15-3 ASSAY FOR THE ADVIA CENTAUR SYSTEMBayer Diagnostics Corp.2002-02-28
K010796AIA-PACK BRCA, ST AIA PACK BRCATosoh Medics, Inc.2001-08-16
K010588ELECSYSCA 15-3 II ASSAYRoche Diagnostics Corp.2001-03-28

Legacy Summary#

summary

FDA Review#

Decision Summary